Expression level of vascular endothelial growth factor in hippocampus is associated with cognitive impairment in patients with Alzheimer's disease

Huidong Tang, Xiao Ou Mao, Lin Xie, David A. Greenberg, Kunlin Jin

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Although the enhanced expression of vascular endothelial growth factor (VEGF) in the brains of patients with Alzheimer's disease (AD) has been reported, the functional significance of VEGF level in the progression of AD is still unclear. We examined the VEGF expression in the hippocampus of patients with AD at different stages of progression by Western blot analysis, and found that the VEGF189 isoform (VEGF189) was barely detectable in normal hippocampus, but significantly increased at the early stage of patients with AD. VEGF189 was decreased with advancing stages of AD. Immunostaining shows that VEGF was significantly increased in the cells in the CA1, CA3, and dentate gyrus regions of hippocampus and layers III and V of entorhinal cortex of patients with AD, compared with normal brain. Confocal images show that VEGF was predominantly expressed in neurons and astrocytes in the hippocampus and entorhinal cortex of patients with AD. Our data suggest that VEGF level is associated with progressive loss of cognitive function in patients with AD.

Original languageEnglish
Pages (from-to)1412-1415
Number of pages4
JournalNeurobiology of Aging
Volume34
Issue number5
DOIs
StatePublished - 1 May 2013

Fingerprint

Vascular Endothelial Growth Factor A
Hippocampus
Alzheimer Disease
Entorhinal Cortex
Parahippocampal Gyrus
Cognitive Dysfunction
Dentate Gyrus
Brain
Astrocytes
Cognition
Protein Isoforms
Western Blotting
Neurons

Keywords

  • Alzheimer's disease
  • Brain
  • Expression
  • Human
  • VEGF

Cite this

@article{7c1b5a2d794b4ba2a337da66f5dd6e48,
title = "Expression level of vascular endothelial growth factor in hippocampus is associated with cognitive impairment in patients with Alzheimer's disease",
abstract = "Although the enhanced expression of vascular endothelial growth factor (VEGF) in the brains of patients with Alzheimer's disease (AD) has been reported, the functional significance of VEGF level in the progression of AD is still unclear. We examined the VEGF expression in the hippocampus of patients with AD at different stages of progression by Western blot analysis, and found that the VEGF189 isoform (VEGF189) was barely detectable in normal hippocampus, but significantly increased at the early stage of patients with AD. VEGF189 was decreased with advancing stages of AD. Immunostaining shows that VEGF was significantly increased in the cells in the CA1, CA3, and dentate gyrus regions of hippocampus and layers III and V of entorhinal cortex of patients with AD, compared with normal brain. Confocal images show that VEGF was predominantly expressed in neurons and astrocytes in the hippocampus and entorhinal cortex of patients with AD. Our data suggest that VEGF level is associated with progressive loss of cognitive function in patients with AD.",
keywords = "Alzheimer's disease, Brain, Expression, Human, VEGF",
author = "Huidong Tang and Mao, {Xiao Ou} and Lin Xie and Greenberg, {David A.} and Kunlin Jin",
year = "2013",
month = "5",
day = "1",
doi = "10.1016/j.neurobiolaging.2012.10.029",
language = "English",
volume = "34",
pages = "1412--1415",
journal = "Neurobiology of Aging",
issn = "0197-4580",
publisher = "Elsevier Inc.",
number = "5",

}

Expression level of vascular endothelial growth factor in hippocampus is associated with cognitive impairment in patients with Alzheimer's disease. / Tang, Huidong; Mao, Xiao Ou; Xie, Lin; Greenberg, David A.; Jin, Kunlin.

In: Neurobiology of Aging, Vol. 34, No. 5, 01.05.2013, p. 1412-1415.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Expression level of vascular endothelial growth factor in hippocampus is associated with cognitive impairment in patients with Alzheimer's disease

AU - Tang, Huidong

AU - Mao, Xiao Ou

AU - Xie, Lin

AU - Greenberg, David A.

AU - Jin, Kunlin

PY - 2013/5/1

Y1 - 2013/5/1

N2 - Although the enhanced expression of vascular endothelial growth factor (VEGF) in the brains of patients with Alzheimer's disease (AD) has been reported, the functional significance of VEGF level in the progression of AD is still unclear. We examined the VEGF expression in the hippocampus of patients with AD at different stages of progression by Western blot analysis, and found that the VEGF189 isoform (VEGF189) was barely detectable in normal hippocampus, but significantly increased at the early stage of patients with AD. VEGF189 was decreased with advancing stages of AD. Immunostaining shows that VEGF was significantly increased in the cells in the CA1, CA3, and dentate gyrus regions of hippocampus and layers III and V of entorhinal cortex of patients with AD, compared with normal brain. Confocal images show that VEGF was predominantly expressed in neurons and astrocytes in the hippocampus and entorhinal cortex of patients with AD. Our data suggest that VEGF level is associated with progressive loss of cognitive function in patients with AD.

AB - Although the enhanced expression of vascular endothelial growth factor (VEGF) in the brains of patients with Alzheimer's disease (AD) has been reported, the functional significance of VEGF level in the progression of AD is still unclear. We examined the VEGF expression in the hippocampus of patients with AD at different stages of progression by Western blot analysis, and found that the VEGF189 isoform (VEGF189) was barely detectable in normal hippocampus, but significantly increased at the early stage of patients with AD. VEGF189 was decreased with advancing stages of AD. Immunostaining shows that VEGF was significantly increased in the cells in the CA1, CA3, and dentate gyrus regions of hippocampus and layers III and V of entorhinal cortex of patients with AD, compared with normal brain. Confocal images show that VEGF was predominantly expressed in neurons and astrocytes in the hippocampus and entorhinal cortex of patients with AD. Our data suggest that VEGF level is associated with progressive loss of cognitive function in patients with AD.

KW - Alzheimer's disease

KW - Brain

KW - Expression

KW - Human

KW - VEGF

UR - http://www.scopus.com/inward/record.url?scp=84873442078&partnerID=8YFLogxK

U2 - 10.1016/j.neurobiolaging.2012.10.029

DO - 10.1016/j.neurobiolaging.2012.10.029

M3 - Article

C2 - 23182805

AN - SCOPUS:84873442078

VL - 34

SP - 1412

EP - 1415

JO - Neurobiology of Aging

JF - Neurobiology of Aging

SN - 0197-4580

IS - 5

ER -